MedicineWatch US
Class II Recall

Wells Pharma of Houston LLC

Product
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
Reason
cGMP deviations.
Classification
Class II
Status
Ongoing
Lot
Lot 022326203650432; Exp Date 06/25/2026
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.